Evidence map›Paper›PMID 29479640›Full record

ReviewCurrent urology reports2018

Endoscopic Management of Urethral Stricture: Review and Practice Algorithm for Management of Male Urethral Stricture Disease.

Nathan M Shaw, Krishnan Venkatesan

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07769060 (Efficacy and Safety Evaluation of Lishitonglin Formula in Improving Preoperative Non-Severe Urinary Tract Infections and Lower Urinary Tract Symptoms in Patients With Urethral Stricture), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07769060 phase2active not recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety Evaluation of Lishitonglin Formula in Improving Preoperative Non-Severe Urinary Tract Infections and Lower Urinary Tract Symptoms in Patients With Urethral Stricture

TypeinterventionalSponsorPeking University First HospitalRan2026 to 2028Enrolled120ConditionsUrethra StrictureArmsLishitonglin Formula granules, Oral placebo medication formulated as granules
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Exosomal MiR-381 from M2-polarized macrophages attenuates urethral fibroblasts activation through YAP/GLS1-regulated glutaminolysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A drug-coated balloon treatment for urethral stricture disease: Two-year results from the ROBUST I study.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. A drug-coated balloon treatment for urethral stricture disease: Interim results from the ROBUST I study.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2020
    Article
  16. Article
  17. Article
  18. Modification of minced buccal mucosal graft endourethral urethroplasty: A pilot study.Indian journal of urology : IJU : journal of the Urological Society of India
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nathan M ShawDepartment of Urology, Georgetown University Hospital, 3800 Reservoir Rd NW, PHC 1, Washington, DC, 20037, USA.
Krishnan VenkatesanDepartment of Urology, Medstar Washington Hospital Center, 110 Irving St NW, Suite 3B-19, Washington, DC, 20010, USA. krishnan.venkatesan@medstar.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewMale urethral stricture disease is characterized by the formation of scar tissue within the urethra resulting in lower urinary tract symptoms, infection, and potentially kidney dysfunction. There is significant variability in clinical practice for the treatment of urethral stricture. We sought to summarize the known data on endoscopic management of urethral stricture disease as part of this larger edition on urethral stricture management. RECENT

findingsOlder studies quoted high rates of success with endoscopic management of urethral stricture, including repeated DVIU. There is now evidence to support a limited role of endoscopic intervention in the management of urethral stricture, and especially strong evidence that repeated endoscopic procedures are not effective. There is poor evidence to support the long-term efficacy of endoscopic urethral stricture management. Furthermore, novel advances in adjunctive therapies have not yet demonstrated durable patency. We discuss the limited role of endoscopic management and suggest an algorithm for its use in stricture management.

Indexed as

Urologic Surgical Procedures, MaleAlgorithmsDilatationEndoscopyHumansLower Urinary Tract SymptomsMaleRecurrenceUrethraUrethral StrictureEndoscopic managementMale urethral stricture diseaseUrethral strictureUrosurgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.